Fund profile
Tickers
BBC
Fund manager
Total assets
$10.87 mm
Liabilities
$746.48 k
Net assets
$10.13 mm
Number of holdings
109.00
BBC stock data
109 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
DREYFUS GOVERNMENT CASH MANAGE | 733.44 k | 733.44 k shares | 7.24 | Short-term investment vehicle | Long | USA |
VERA Vera Therapeutics Inc - Ordinary Shares | 203.01 k | 5.57 k shares | 2.00 | Common equity | Long | USA |
RYZB RayzeBio Inc. | 191.64 k | 3.09 k shares | 1.89 | Common equity | Long | USA |
CYTK Cytokinetics Inc | 175.17 k | 2.24 k shares | 1.73 | Common equity | Long | USA |
AMAM Ambrx Biopharma Inc. | 169.50 k | 6.10 k shares | 1.67 | Common equity | Long | USA |
DYN Dyne Therapeutics Inc | 148.58 k | 6.94 k shares | 1.47 | Common equity | Long | USA |
CGEM Cullinan Therapeutics Inc | 146.00 k | 9.64 k shares | 1.44 | Common equity | Long | USA |
Liquidia Corporation | 143.86 k | 11.26 k shares | 1.42 | Common equity | Long | USA |
SYRE Spyre Therapeutics Inc. | 143.28 k | 5.53 k shares | 1.41 | Common equity | Long | USA |
KURA Kura Oncology Inc | 138.30 k | 6.87 k shares | 1.37 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 134.58 k | 2.43 k shares | 1.33 | Common equity | Long | USA |
IGMS IGM Biosciences Inc | 132.82 k | 12.63 k shares | 1.31 | Common equity | Long | USA |
MGNX Macrogenics Inc | 126.04 k | 8.81 k shares | 1.24 | Common equity | Long | USA |
RNA Avidity Biosciences Inc | 124.98 k | 10.22 k shares | 1.23 | Common equity | Long | USA |
ARDX Ardelyx Inc | 123.52 k | 14.15 k shares | 1.22 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc | 121.85 k | 31.09 k shares | 1.20 | Common equity | Long | USA |
CMPS Compass Pathways Plc | 119.80 k | 10.63 k shares | 1.18 | Common equity | Long | UK |
APGE Apogee Therapeutics Inc. | 118.29 k | 3.53 k shares | 1.17 | Common equity | Long | USA |
KRTX Karuna Therapeutics Inc | 117.53 k | 375.00 shares | 1.16 | Common equity | Long | USA |
MRUS Merus N.V | 115.82 k | 3.25 k shares | 1.14 | Common equity | Long | Netherlands |
ALPN Alpine Immune Sciences Inc | 115.67 k | 4.35 k shares | 1.14 | Common equity | Long | USA |
INBX Inhibrx Inc | 114.82 k | 2.98 k shares | 1.13 | Common equity | Long | USA |
SANA Sana Biotechnology Inc | 112.91 k | 20.57 k shares | 1.11 | Common equity | Long | USA |
MLYS Mineralys Therapeutics Inc | 108.52 k | 9.95 k shares | 1.07 | Common equity | Long | USA |
ALLO Allogene Therapeutics Inc | 106.59 k | 30.28 k shares | 1.05 | Common equity | Long | USA |
KYMR Kymera Therapeutics Inc | 105.72 k | 3.23 k shares | 1.04 | Common equity | Long | USA |
BMEA Biomea Fusion Inc | 105.59 k | 5.84 k shares | 1.04 | Common equity | Long | USA |
RAPT RAPT Therapeutics Inc | 105.01 k | 4.24 k shares | 1.04 | Common equity | Long | USA |
IDYA Ideaya Biosciences Inc | 104.38 k | 2.40 k shares | 1.03 | Common equity | Long | USA |
VKTX Viking Therapeutics Inc | 103.08 k | 4.27 k shares | 1.02 | Common equity | Long | USA |
SLNO Soleno Therapeutics Inc | 102.29 k | 2.21 k shares | 1.01 | Common equity | Long | USA |
ANAB AnaptysBio Inc | 101.72 k | 4.31 k shares | 1.00 | Common equity | Long | USA |
ACLX Arcellx Inc | 98.94 k | 1.60 k shares | 0.98 | Common equity | Long | USA |
PTGX Protagonist Therapeutics Inc | 98.81 k | 3.95 k shares | 0.98 | Common equity | Long | USA |
ZYME Zymeworks Inc. | 98.62 k | 9.10 k shares | 0.97 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals Inc | 98.24 k | 8.94 k shares | 0.97 | Common equity | Long | USA |
BHVN Biohaven Ltd. | 96.97 k | 2.18 k shares | 0.96 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 96.70 k | 1.35 k shares | 0.95 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 96.50 k | 2.93 k shares | 0.95 | Common equity | Long | USA |
BCYC Bicycle Therapeutics Plc | 95.47 k | 5.47 k shares | 0.94 | Common equity | Long | UK |
ARVN Arvinas Inc | 95.45 k | 2.30 k shares | 0.94 | Common equity | Long | USA |
IMTX Immatics N.V | 95.13 k | 8.37 k shares | 0.94 | Common equity | Long | Germany |
TNGX Tango Therapeutics Inc | 94.63 k | 8.05 k shares | 0.93 | Common equity | Long | USA |
IRON Disc Medicine Inc | 92.58 k | 1.41 k shares | 0.91 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 92.29 k | 2.88 k shares | 0.91 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc | 89.99 k | 1.99 k shares | 0.89 | Common equity | Long | Canada |
PGEN Precigen Inc | 89.88 k | 65.13 k shares | 0.89 | Common equity | Long | USA |
ALXO Alx Oncology Holdings Inc | 89.66 k | 6.22 k shares | 0.89 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 89.15 k | 3.79 k shares | 0.88 | Common equity | Long | USA |
MORF Morphic Holding Inc | 88.00 k | 2.78 k shares | 0.87 | Common equity | Long | USA |
PLRX Pliant Therapeutics Inc | 87.70 k | 4.89 k shares | 0.87 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 87.08 k | 3.14 k shares | 0.86 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals Inc | 86.86 k | 6.66 k shares | 0.86 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals Inc | 86.60 k | 5.75 k shares | 0.86 | Common equity | Long | USA |
SLRN Acelyrin Inc | 85.89 k | 11.27 k shares | 0.85 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals Inc | 85.84 k | 2.35 k shares | 0.85 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics Inc | 85.23 k | 4.94 k shares | 0.84 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals Inc | 84.58 k | 4.13 k shares | 0.84 | Common equity | Long | USA |
NMRA Neumora Therapeutics Inc. | 83.57 k | 5.61 k shares | 0.83 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 83.37 k | 2.90 k shares | 0.82 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 82.28 k | 10.64 k shares | 0.81 | Common equity | Long | USA |
REPL Replimune Group Inc | 82.07 k | 10.58 k shares | 0.81 | Common equity | Long | USA |
CABA Cabaletta Bio Inc | 81.82 k | 4.00 k shares | 0.81 | Common equity | Long | USA |
VRDN Viridian Therapeutics Inc | 81.68 k | 4.24 k shares | 0.81 | Common equity | Long | USA |
CRBU Caribou Biosciences Inc | 81.53 k | 13.30 k shares | 0.81 | Common equity | Long | USA |
EXAI Exscientia Plc | 81.09 k | 13.91 k shares | 0.80 | Common equity | Long | UK |
RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | 81.03 k | 8.61 k shares | 0.80 | Common equity | Long | USA |
BLTE Belite Bio Inc | 80.69 k | 1.86 k shares | 0.80 | Common equity | Long | USA |
CLDX Celldex Therapeutics Inc. | 79.95 k | 2.27 k shares | 0.79 | Common equity | Long | USA |
MLTX MoonLake Immunotherapeutics - Ordinary Shares | 79.52 k | 1.42 k shares | 0.79 | Common equity | Long | Switzerland |
AKRO Akero Therapeutics Inc | 79.46 k | 3.68 k shares | 0.78 | Common equity | Long | USA |
KRYS Krystal Biotech Inc | 78.54 k | 706.00 shares | 0.78 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 78.14 k | 6.05 k shares | 0.77 | Common equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 78.10 k | 1.04 k shares | 0.77 | Common equity | Long | USA |
VIR Vir Biotechnology Inc | 76.83 k | 8.17 k shares | 0.76 | Common equity | Long | USA |
ABCL AbCellera Biologics Inc | 76.52 k | 14.98 k shares | 0.76 | Common equity | Long | Canada |
MDGL Madrigal Pharmaceuticals Inc | 76.28 k | 352.00 shares | 0.75 | Common equity | Long | USA |
RLAY Relay Therapeutics Inc | 76.21 k | 8.24 k shares | 0.75 | Common equity | Long | USA |
ITOS ITeos Therapeutics Inc | 75.81 k | 7.62 k shares | 0.75 | Common equity | Long | USA |
ETNB 89bio Inc | 75.36 k | 7.61 k shares | 0.74 | Common equity | Long | USA |
LYEL Lyell Immunopharma Inc | 74.34 k | 40.63 k shares | 0.73 | Common equity | Long | USA |
TGTX TG Therapeutics Inc | 74.04 k | 4.56 k shares | 0.73 | Common equity | Long | USA |
COGT Cogent Biosciences Inc | 73.29 k | 16.55 k shares | 0.72 | Common equity | Long | USA |
NRIX Nurix Therapeutics Inc | 72.51 k | 9.18 k shares | 0.72 | Common equity | Long | USA |
XNCR Xencor Inc | 72.31 k | 3.87 k shares | 0.71 | Common equity | Long | USA |
AGEN Agenus Inc | 71.93 k | 107.81 k shares | 0.71 | Common equity | Long | USA |
RCUS Arcus Biosciences Inc | 70.46 k | 4.65 k shares | 0.70 | Common equity | Long | USA |
IMVT Immunovant Inc | 70.16 k | 1.93 k shares | 0.69 | Common equity | Long | USA |
GERN Geron Corp. | 68.32 k | 37.13 k shares | 0.67 | Common equity | Long | USA |
IBRX ImmunityBio Inc | 67.75 k | 20.16 k shares | 0.67 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 67.22 k | 2.76 k shares | 0.66 | Common equity | Long | USA |
TERN Terns Pharmaceuticals Inc | 65.60 k | 12.66 k shares | 0.65 | Common equity | Long | USA |
SAVA Cassava Sciences Inc | 65.29 k | 2.73 k shares | 0.64 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals Inc | 65.01 k | 5.49 k shares | 0.64 | Common equity | Long | USA |
VERV Verve Therapeutics Inc | 62.01 k | 5.73 k shares | 0.61 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corp | 61.67 k | 4.42 k shares | 0.61 | Common equity | Long | USA |
PHAT Phathom Pharmaceuticals Inc | 61.57 k | 9.19 k shares | 0.61 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 61.36 k | 2.58 k shares | 0.61 | Common equity | Long | USA |
ALEC Alector Inc | 61.14 k | 10.26 k shares | 0.60 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc | 61.07 k | 1.40 k shares | 0.60 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 59.70 k | 2.10 k shares | 0.59 | Common equity | Long | Ireland |
NVAX Novavax, Inc. | 57.69 k | 14.42 k shares | 0.57 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc | 56.68 k | 3.54 k shares | 0.56 | Common equity | Long | USA |
QURE uniQure N.V. | 56.33 k | 10.13 k shares | 0.56 | Common equity | Long | Netherlands |
EDIT Editas Medicine Inc | 53.22 k | 7.57 k shares | 0.53 | Common equity | Long | USA |
CVAC CureVac N.V. | 50.97 k | 14.20 k shares | 0.50 | Common equity | Long | Germany |
RGNX Regenxbio Inc | 48.57 k | 3.94 k shares | 0.48 | Common equity | Long | USA |
ALLK Allakos Inc | 33.09 k | 26.05 k shares | 0.33 | Common equity | Long | USA |
SCLX Scilex Holding Company | 27.48 k | 17.64 k shares | 0.27 | Common equity | Long | USA |